CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- 4 Shares withheld for taxes Chf Scientific Operations Off gave up 3,049 shares (to pay taxes)
- 4 Grant or award Chief Financial Officer acquired 22,000 shares (grant or award)
- 4 Shares withheld for taxes VP, Controller gave up 904 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 5,746 shares (to pay taxes)
- 4 Shares withheld for taxes Chf Scientific Operations Off gave up 5,229 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,877 shares (to pay taxes)
- 4 Shares withheld for taxes Chf Scientific Operations Off gave up 1,899 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 5,840 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Controller gave up 324 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Controller gave up 10,075 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 682 shares (to pay taxes)
- 4 Gift CEO and President gave 9,310 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 20 · 382 filings